95 related articles for article (PubMed ID: 22226863)
1. The effect of passages during Japanese BCG vaccine production on genetic stability and protective efficacy.
Seki M; Udagawa T; Sugawara I; Iwama K; Honda I; Fujita I; Hashimoto A; Yano I; Yamamoto S
Vaccine; 2012 Feb; 30(8):1460-4. PubMed ID: 22226863
[TBL] [Abstract][Full Text] [Related]
2. Preparation of a working seed lot of BCG and quality control by PCR genotyping.
Trovero A; Argüelles C; Cataldi A
Rev Argent Microbiol; 2010; 42(1):4-10. PubMed ID: 20461286
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains].
Prygiel M; Janaszek-Seydlitz W; Bucholc B
Przegl Epidemiol; 2011; 65(4):621-8. PubMed ID: 22390050
[TBL] [Abstract][Full Text] [Related]
4. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
5. Quantification of two variant strains contained in freeze-dried Japanese BCG vaccine preparation by real-time PCR.
Shibayama K; Mochida K; Yagi T; Mori S; Arakawa Y; Yamamoto S
Biologicals; 2007 Apr; 35(2):139-43. PubMed ID: 17074509
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
de Lisle GW; Wards BJ; Buddle BM; Collins DM
Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
[TBL] [Abstract][Full Text] [Related]
7. An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine.
Wards BJ; de Lisle GW; Collins DM
Tuber Lung Dis; 2000; 80(4-5):185-9. PubMed ID: 11052907
[TBL] [Abstract][Full Text] [Related]
8. Report of an international collaborative study to evaluate the suitability of multiplex PCR as an identity assay for different sub-strains of BCG vaccine.
Markey K; Ho MM; Choudhury B; Seki M; Ju L; Castello-Branco LR; Gairola S; Zhao A; Shibayama K; Andre M; Corbel MJ
Vaccine; 2010 Oct; 28(43):6964-9. PubMed ID: 20732463
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
Sugawara I; Udagawa T; Taniyama T
Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
[TBL] [Abstract][Full Text] [Related]
10. [BCG: substrains, the vaccine, vaccination].
Balazs ED
Bacteriol Virusol Parazitol Epidemiol; 1997; 42(3):117-24. PubMed ID: 9417279
[No Abstract] [Full Text] [Related]
11. Descendant of daughter Brazilian BCG Moreau substrain in Poland.
Krysztopa-Grzybowska K; Brzezińska S; Augustynowicz-Kopeć E; Polak M; Augustynowicz E; Lutyńska A
Vaccine; 2012 Aug; 30(37):5512-8. PubMed ID: 22749596
[TBL] [Abstract][Full Text] [Related]
12. Mapping the global use of different BCG vaccine strains.
Ritz N; Curtis N
Tuberculosis (Edinb); 2009 Jul; 89(4):248-51. PubMed ID: 19540166
[TBL] [Abstract][Full Text] [Related]
13. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
[TBL] [Abstract][Full Text] [Related]
14. Historical review of BCG vaccine in Japan.
Yamamoto S; Yamamoto T
Jpn J Infect Dis; 2007 Nov; 60(6):331-6. PubMed ID: 18032829
[TBL] [Abstract][Full Text] [Related]
15. Microevolution of BCG substrains.
Krysztopa-Grzybowska K; Lutyńska A
Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1259-1266. PubMed ID: 28026828
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein.
Deng Y; Bao L; Yang X
Microbiol Immunol; 2011 Nov; 55(11):798-808. PubMed ID: 21831202
[TBL] [Abstract][Full Text] [Related]
17. Potential correlates of BCG induced protection against tuberculosis detected in a mouse aerosol model using gene expression profiling.
Rodgers A; Whitmore KM; Walker KB
Tuberculosis (Edinb); 2006; 86(3-4):255-62. PubMed ID: 16600686
[TBL] [Abstract][Full Text] [Related]
18. Multiplex-PCR as an identity assay for Mycobacterium bovis BCG Moreau descendants.
Krysztopa-Grzybowska K; Brzezińska S; Augustynowicz-Kopeć E; Polak M; Lutyńska A
Biologicals; 2013 May; 41(3):197-200. PubMed ID: 23490534
[TBL] [Abstract][Full Text] [Related]
19. Divergence of immunologic and protective responses of different BCG strains in a murine model.
Kozak R; Behr MA
Vaccine; 2011 Feb; 29(7):1519-26. PubMed ID: 21184855
[TBL] [Abstract][Full Text] [Related]
20. The effect of passaging in liquid media and storage on Mycobacterium bovis--BCG growth capacity and infectivity.
Nascimento IP; Leite LC
FEMS Microbiol Lett; 2005 Feb; 243(1):81-6. PubMed ID: 15668004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
